MARKET

APDN

APDN

Applied Dna Scie
NASDAQ
0.3700
+0.0370
+11.11%
Opening 11:13 04/18 EDT
OPEN
0.3378
PREV CLOSE
0.3330
HIGH
0.3700
LOW
0.3300
VOLUME
93.43K
TURNOVER
0
52 WEEK HIGH
1.860
52 WEEK LOW
0.3131
MARKET CAP
6.28M
P/E (TTM)
-0.6782
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at APDN last week (0408-0412)?
Weekly Report · 3d ago
Weekly Report: what happened at APDN last week (0401-0405)?
Weekly Report · 04/08 09:56
Weekly Report: what happened at APDN last week (0325-0329)?
Weekly Report · 04/01 09:56
Weekly Report: what happened at APDN last week (0318-0322)?
Weekly Report · 03/25 09:58
12 Health Care Stocks Moving In Wednesday's After-Market Session
XTL Biopharmaceuticals (NASDAQ:XTLB) shares moved upwards by 13.9% to $2.71 during Wednesday's after-market session. The company's Q4 earnings report came out 2 days ago. Jaguar Health and Leap Therapeutics were among the gainers.
Benzinga · 03/20 21:34
12 Health Care Stocks Moving In Monday's Pre-Market Session
Applied DNA Sciences (APDN) stock moved upwards by 33.1% to $0.49 during Monday's pre-market session. XTL Biopharmaceuticals (XTLB) shares increased by 19.31%. 2seventy bio (TSVT) shares rose 17.7%. Titan Pharma (TTNP) shares declined by 18.2% during the session.
Benzinga · 03/18 13:05
Weekly Report: what happened at APDN last week (0311-0315)?
Weekly Report · 03/18 09:57
Applied DNA Sciences files to sell 11.29M shares of common stock for holders
Applied DNA Sciences files to sell 11.29M shares of common stock for holders. Applied DNA Sciences, Inc. Filed a prospectus related to the proposed resale of shares by the selling stockholders. This prospectus is not an offer to sell these securities.
Seeking Alpha · 03/12 15:58
More
About APDN
Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes. It also develops PCR-based molecular in vitro diagnostics for covid-19. In addition, under its wholly owned subsidiary, Applied DNA Clinical Labs, LLC, the Company is offering a high-throughput turnkey solution for population-scale Covid-19 testing marketed as safeCircle. safeCircle utilizes the Company’s Covid-19 Diagnostic Tests and is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies.

Webull offers Applied DNA Sciences Inc stock information, including NASDAQ: APDN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APDN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading APDN stock methods without spending real money on the virtual paper trading platform.